Suppression of Pathological Allergen-Specific B Cells by Protein-Engineered Molecules in a Mouse Model of Chronic House Dust Mite Allergy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413661 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nikola Ralchev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Mice, Inbred BALB C, Disease Models, Animal, Antigens, Dermatophagoides, Hypersensitivity. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, the European Fund for regional development through Operational Program Science and Educa-tion for Smart Growth 2014 - 2020, National Science Fund, Bulgaria.
Abstract (Originalsprache)
Der p1 is one of the major allergens causing house dust mite (HDM) allergy. Pathological Der p1-specific B cells play a key role in allergic inflammation as producers of allergen-specific antibodies. Crosslinking the inhibitory FcγRIIb with the B cell receptor triggers a high-affinity suppressive signal in B cells. Selective elimination of allergen-specific cells could potentially be achieved by administering chimeric molecules that combine, through protein engineering, the FcγRIIb-targeting monoclonal 2.4G2 antibody with the epitope-carrying Dp52–71 peptides from Der p1. We tested this hypothesis, in a chronic mouse model of HDM allergy induced in BalB/c mice, using FACS and ELISA assays, along with histopathological and correlational analyses. Dp52–71chimera treatment of HDM-challenged mice led to a decrease in serum anti-HDM IgG1 antibodies, a reduction in BALF β-hexosaminidase levels, a lowered number of SiglecFhigh CD11clow eosinophils, and an improved lung PAS score. Furthermore, we observed overexpression of FcγRIIb on the surface of CD19 cells in the lungs of HDM-challenged animals, which negatively correlated with the levels of lung alveolar macrophages, neutrophils, and BALF IL-13. Taken together, these results suggest that the use of FcγRIIb overexpression, combined with the expansion of chimeric protein technology to include more epitopes, could improve the outcome of inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
ORCID-Profile: Nikola Ralchev, Nikolina Mihaylova
Förderung
- Bulgarian Science Fund
- the European Fund for regional development through Operational Program Science and Educa-tion for Smart Growth 2014 - 2020
- National Science Fund, Bulgaria
- Programme “Scientific Research, Innovation and Digitalisation for Smart Transformation” 2021-2027 (PNIIDIT)
Zitieren
APA
Ralchev, N., Bradyanova, S., Kerekov, N., Tchorbanov, A., & Mihaylova, N. (2024). Suppression of Pathological Allergen-Specific B Cells by Protein-Engineered Molecules in a Mouse Model of Chronic House Dust Mite Allergy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413661
Vancouver
Ralchev N, Bradyanova S, Kerekov N, Tchorbanov A, Mihaylova N. Suppression of Pathological Allergen-Specific B Cells by Protein-Engineered Molecules in a Mouse Model of Chronic House Dust Mite Allergy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413661
BibTeX
@article{Ralchev2024,
author = {Ralchev, Nikola and Bradyanova, Silviya and Kerekov, Nikola and Tchorbanov, Andrey and Mihaylova, Nikolina},
title = {Suppression of Pathological Allergen-Specific B Cells by Protein-Engineered Molecules in a Mouse Model of Chronic House Dust Mite Allergy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413661}
}
EUVIMED